Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Open Posted

Opportunity number
PAR-24-272
Agency
Applications due
Award size
Not on record

Opportunity facts

Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • Special District Governments
  • For Profit Organizations
  • Higher Education Inst. (Public)
  • Public or Indian Housing Auth.
  • Non-501(c)(3) Nonprofits
  • Tribal Governments (Federally Recognized)
  • Tribal Organizations (Not Federally Recognized)
  • State Governments
  • 501(c)(3) Nonprofits
  • Small Businesses
  • Independent School Districts
  • Higher Education Inst. (Private)
  • Other
  • County Governments
  • City/Township Governments
Points of contact
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Center for Advancing Translational Sciences (NCATS) is soliciting applications for Clinical and Translational Science Award (CTSA) Program hubs under a cooperative agreement with an application due date of September 28, 2027. The CTSA Program is a national collaborative consortium advancing clinical and translational science through scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification through community health dissemination.

Eligible applicants include 501(c)(3) nonprofits, state and local governments, higher education institutions (public and private), small businesses, special district governments, county governments, city and township governments, independent school districts, for-profit organizations, tribal governments and organizations, public or Indian housing authorities, non-501(c)(3) nonprofits, and other entities. The announcement also identifies as eligible Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, regional organizations, U.S. territories and possessions, and eligible federal agencies. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible; foreign components as defined in the NIH Grants Policy Statement are allowed.

The funding instrument is a cooperative agreement utilizing the UM1 activity code under Assistance Listing 93.350 (National Center for Advancing Translational Sciences). The program objectives include developing and disseminating scientific and operational innovations; promoting partnerships locally, regionally, and nationally; addressing health disparities; improving clinical research quality, safety, and efficiency; providing rapid-response resources for urgent public health needs; and delivering clinical and translational science training for clinical research professionals.

Peer review assesses scientific merit and significance, technical adequacy of design, investigator competency, facility adequacy, budget necessity, and relevance to program objectives. The NCATS Advisory Council conducts second-level review and makes award recommendations.

Synopsis

This Notice of Funding Opportunity announcement (NOFO) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments for all people more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; See Funding Opportunity for eligibility criteria. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Files

File Type Posted
PAR-24-272-Full-Announcement.html HTML file
PKG00288366.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity